Company intelligence / Profile preview
CGBio
Seoul, South Koreacgbio.co.kr ↗
- Ownership
- Private
- Employees
- ~300
- Development stage
- Commercial
01
Overview
CGBio has commercialized a range of products for bone regeneration/spinal fusion using recombinant human BMP2 and synthetic/allograft bone grafts. The company also markets advanced wound care solutions and aesthetic products such as HA and calcium hydroxyapatite fillers. It recently received FDA IDE approval for NOVOSIS PUTTY in the U.S., indicating late-stage clinical development or market entry for some products[1]. The company’s regenerative medicine portfolio includes both medical device and biologic approaches.
- Therapeutic areas
- OtherDermatologyNeurology
- Modalities
- BiologicRecombinant proteinGrowth factor therapyTissue scaffold-based therapyCell solution biotechnologyHydrogel-based drug delivery therapy
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Shanghai Sanyou Medical (China JV Sol Cent Bio)[4]global supply deals with partners in Latin America/Africa/Asia/U.S.[1][4]license-out agreement in China for FACETEM ($100M)[5]
Beyond the preview
Go deeper on CGBio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CGBio.